PracticeBlogFlashcardsEspañol
All Practice Exams

299+ Free IN MPJE Practice Questions

Pass your Indiana Multistate Pharmacy Jurisprudence Examination exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately
Not publicly reported Pass Rate
299+ Questions
100% Free
1 / 299
Question 1
Score: 0/0

Under the Controlled Substances Act (CSA), which DEA schedule includes drugs with the highest potential for abuse and no currently accepted medical use?

A
B
C
D
to track
2026 Statistics

Key Facts: IN MPJE Exam

120

Questions

100 scored + 20 pretest

75

Passing Score

NABP scaled score

2.5h

Exam Time

Pearson VUE

1:4

Tech Ratio

IN max

30h/2yr

CE Required

IN renewal

$270

Exam Fee

NABP 2026

The IN MPJE covers federal pharmacy law (DEA, FDA, CSA, HIPAA) and Indiana-specific regulations including INSPECT program (PMP) mandatory checks, 4:1 technician ratio, collaborative practice agreements, pharmacist immunization authority, central fill pharmacy authorization, 1:4 technician ratio, and 30h/2yr CE requirement.

Sample IN MPJE Practice Questions

Try these sample questions to test your IN MPJE exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 299+ question experience with AI tutoring.

1Under the Controlled Substances Act (CSA), which DEA schedule includes drugs with the highest potential for abuse and no currently accepted medical use?
A.Schedule I
B.Schedule II
C.Schedule III
D.Schedule IV
Explanation: Schedule I substances have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. Examples include heroin, LSD, and MDMA.
2A DEA Form 222 is required for the transfer of which schedule of controlled substances between registrants?
A.Schedule II only
B.Schedules II and III
C.Schedules III through V
D.All controlled substances
Explanation: DEA Form 222 (or its electronic equivalent under CSOS) is required for the distribution and transfer of Schedule II controlled substances between DEA registrants.
3Under federal law, what is the maximum number of refills allowed for a Schedule III controlled substance prescription?
A.No refills allowed
B.Up to 3 refills within 6 months
C.Up to 5 refills within 6 months
D.Up to 5 refills within 1 year
Explanation: Federal law allows up to 5 refills for Schedule III-V controlled substance prescriptions within 6 months from the date the prescription was issued.
4The Durham-Humphrey Amendment of 1951 established which key distinction in drug classification?
A.Generic vs. brand-name drugs
B.Prescription (legend) vs. over-the-counter drugs
C.Controlled vs. non-controlled substances
D.Biological vs. chemical drugs
Explanation: The Durham-Humphrey Amendment to the Federal Food, Drug, and Cosmetic Act established the distinction between prescription (legend) drugs and over-the-counter (OTC) drugs.
5Which federal law requires pharmacists to offer counseling to Medicaid patients on new prescriptions?
A.HIPAA
B.OBRA '90
C.DSCSA
D.Kefauver-Harris Amendment
Explanation: The Omnibus Budget Reconciliation Act of 1990 (OBRA '90) requires pharmacists to offer counseling to Medicaid patients receiving new prescriptions and to perform prospective drug utilization review (DUR).
6Under the Poison Prevention Packaging Act (PPPA), which medication is exempt from child-resistant packaging?
A.Amoxicillin suspension
B.Sublingual nitroglycerin
C.Lisinopril tablets
D.Metformin tablets
Explanation: Sublingual nitroglycerin is exempt from child-resistant packaging under the PPPA due to the need for immediate emergency access.
7What is the maximum days' supply of a Schedule II controlled substance that can be prescribed via emergency oral prescription under federal law?
A.72-hour supply
B.7-day supply
C.14-day supply
D.30-day supply
Explanation: In an emergency, a pharmacist may dispense a Schedule II controlled substance based on an oral prescription, limited to a quantity adequate for the emergency period (typically 72 hours). A written follow-up is required within 7 days.
8Under HIPAA, which of the following is considered protected health information (PHI)?
A.De-identified aggregate prescription data
B.A patient's prescription fill history linked to their name
C.Published clinical trial results
D.General drug interaction information
Explanation: PHI under HIPAA includes any individually identifiable health information, including prescription records linked to a patient's name.
9The Drug Supply Chain Security Act (DSCSA) requires pharmacies to maintain transaction records for how long?
A.2 years
B.4 years
C.6 years
D.10 years
Explanation: Under the DSCSA, pharmacies must maintain transaction information, history, and statements for at least 6 years from the date of the transaction.
10A DEA registrant must take an initial inventory of controlled substances on what date?
A.Within 30 days of opening
B.On the date the registrant first engages in controlled substance activity
C.Within 90 days of DEA registration
D.On January 1 of each year
Explanation: A DEA registrant must take an initial inventory on the date the registrant first engages in the manufacture, distribution, or dispensing of controlled substances.

About the IN MPJE Exam

The Indiana MPJE tests knowledge of federal pharmacy law and Indiana-specific pharmacy regulations under Indiana Code Title 25, Article 26 (Pharmacy Practice Act). Required alongside the NAPLEX for pharmacist licensure in Indiana.

Questions

120 scored questions

Time Limit

2.5 hours

Passing Score

75 (scaled score)

Exam Fee

$270 (NABP / Indiana Board of Pharmacy)

IN MPJE Exam Content Outline

22%

Licensure & Personnel

Pharmacist qualifications, intern/technician requirements, license renewal, disciplinary actions

33%

Pharmacist Practice

Prescription requirements, counseling, controlled substance rules, collaborative practice agreements

24%

Dispensing Requirements

Generic substitution, prescription transfers, DUR, labeling, PDMP checking

21%

Pharmacy Operations

Controlled substance records, compounding standards, pharmacy permits, automated dispensing

How to Pass the IN MPJE Exam

What You Need to Know

  • Passing score: 75 (scaled score)
  • Exam length: 120 questions
  • Time limit: 2.5 hours
  • Exam fee: $270

Keys to Passing

  • Complete 500+ practice questions
  • Score 80%+ consistently before scheduling
  • Focus on highest-weighted sections
  • Use our AI tutor for tough concepts

IN MPJE Study Tips from Top Performers

1Study Indiana Code Title 25, Article 26 (Pharmacy Practice Act) for Indiana-specific pharmacy regulations
2Master DEA controlled substance schedules, forms (222, 106, 41), and corresponding responsibility
3Know Indiana PDMP requirements and mandatory query triggers for Schedule II-V substances
4Review Indiana naloxone access laws and collaborative practice agreements
5Understand federal vs. state law conflicts — the more restrictive law prevails

Frequently Asked Questions

What is the IN MPJE passing score?

The Indiana MPJE requires a scaled score of 75. The exam has 120 questions (100 scored, 20 pretest) over 2.5 hours at Pearson VUE.

What Indiana laws are tested?

The IN MPJE covers Indiana Code Title 25, Article 26 (Pharmacy Practice Act), Indiana Code Title 35, Article 48 (Controlled Substances Act), Indiana Board of Pharmacy rules, PDMP requirements, and state-specific dispensing regulations.

What is the technician ratio in Indiana?

Indiana allows a 1:4 pharmacist-to-technician ratio. Technicians must be registered with the Indiana Board of Pharmacy and work under direct pharmacist supervision.

How many CE hours does Indiana require?

Indiana requires 30h/2yr of continuing education per renewal period. CE must be ACPE-accredited.

Does Indiana require PDMP checks?

Yes, Indiana requires pharmacists to check the PDMP before dispensing Schedule II-V controlled substances.